The country’s leading quoted CBD wellness and medicinal cannabis group

About us

CBD you can trust

Sativa Group plc is the UK’s leading quoted CBD wellness and medicinal cannabis group with four revenue generating operating subsidiaries. It also has a research division that holds Home Office licences, and is developing medicines for the veterinary and human markets, supported by our Scientific Advisory Board.

Our Mission

Sativa Group’s strategy is focused on the smart-sourcing of the raw materials, advanced extraction, manufacture, testing, distribution, as well as the research & development, of medicinal cannabis and cannabinoid products.

Our Vision

To build the UK’s leading CBD Wellness brands and to develop innovative medicinal and veterinary cannabis products to answer the unmet needs of consumers and patients.

Latest updates

Sativa Investments commits to C$ 0.2 million investment in Canadian-based Veritas Pharma

Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, has subscribed for 500,000 new shares at C$ 0.40 per share, at a cost of C$ 0.2 million cash, in Canadian-based emerging global pharmaceutical company Veritas Pharma Inc (or “Veritas Pharma”), which is tri-listed on the Canadian Securities Exchange, America’s OTC exchange and the Frankfurt Stock Exchange.

Orderly Market Agreement – Director’s Dealing

Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, announces that, on 16 April 2018, Noel Lyons, a non-executive director of the Company, sold 750,000 ordinary shares of £0.0025 each in the Company at a price of £0.03 per share pursuant to an orderly market agreement with Peterhouse Corporate Finance Limited to satisfy market demand.

Sativa Investments PLC MOU with George Botanicals

Sativa Investments PLC [NEX:SATI], the UK’s first medicinal cannabis investment vehicle, has signed a Memorandum of Understanding (“MOU”) with George Botanicals Ltd, a UK-based manufacturer, wholesaler and distributor of wellness CBD products, to purchase a 51 per cent shareholding from its owner, Carbon Managers Limited (“Carbon Managers”) for an expected consideration of circa £200,000. George Botanicals has been providing its customers with high quality natural CBD products since September 2017, including vape pens, balms, E-Liquids, drops and edible gels that are shipped throughout the UK and are 100 per cent laboratory tested.

Niche, innovative brands tailored to each audience

Goodbody Botanicals is aimed at the UK’s major grocers, high street pharmacies and retailers, as well as independent pharmacies throughout the country. The brand and packaging is seen as industry-leading by numerous retailers.
Goodbody Wellness focuses on the health and beauty markets. The brand sells products to specialty retailers as well as through three company-owned Goodbody Wellness stores.

Tessellate Collective sells CBD products through the direct marketing channel.

PhytoVista Laboratories is a leading UK testing laboratory for cannabis-based CBD products.


Backed up by a laboratory

Sativa brings together professionals with extensive commercial, retail, finance, medical, veterinary, pharmacological, scientific, governance and regulatory experience and is working in conjunction with King’s College London on research to develop innovative solutions that meet consumer and patient demand.